Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 187
Selected: 0
NCT IDTitle
NCT00053092Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma
NCT00392535Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer
NCT05990192SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
NCT02388230Quantification of Breast RadioTherapy Associated Late Toxicity Using Novel UltraSound Techniques
NCT02296801A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
NCT02541266Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation
NCT04359420What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol
NCT01332968A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
NCT03506997Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer
NCT00107497Radiation Therapy in Treating Women With Localized Breast Cancer
NCT01977638Phase 1 Trial of CXD101 in Patients With Advanced Cancer
NCT02388308Evaluation of Clarity Ultrasound Guidance for Prostate Therapy
NCT04117594Whole Body Magnetic Resonance Imaging Study
NCT03327662Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer
NCT00261456The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
NCT02753569Imaging NSCLC Treatment Response to Immunotherapy
NCT01395121A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread
NCT04270799Lung Nodule Imaging Biobank for Radiomics and AI Research
NCT05082259ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
NCT06636526The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).
NCT04595019Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer
NCT04084145National Unified Renal Translation Research Enterprise - Chronic Kidney Disease
NCT04686188Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer
NCT02759783Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases
NCT04584853PreOperative Endocrine Therapy for Individualised Care With Abemaciclib
NCT00077168Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
NCT00079248Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer
NCT00818051Radiation Therapy in Treating Women Who Have Undergone Breast Conservation Surgery and Systemic Therapy for Early Breast Cancer
NCT02409212Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer
NCT04659252CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid-19)
NCT01737242UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies
NCT03946202KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer
NCT05741801Digital Alerts for Sepsis: a Qualitative Study
NCT03809377Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)
NCT02389842PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib
NCT03466944PUMA (Paediatric Osseous Marrow Assessment)
NCT01693822A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy
NCT00867347Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer
NCT00052455Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
NCT066302605G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
NCT03479151Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU) for Pain Palliation of Bone Metastases
NCT01000129Adaptive Planning in Bladder Cancer
NCT03574454Machine Learning in Myeloma Response
NCT00692354Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours
NCT01567137MR Characterisation/Localisation of Breast Cancer
NCT05368298SCOOT: Sample Collection for DART
NCT02403102Imageguided Theranostics in Multiple Myeloma
NCT00028756Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
NCT02780375Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects
NCT01104571Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer